Transthyretin related familial amyloid polyneuropathy

Current Opinion in Neurology

Volumn 13, Issue 5, 2000, Pages 569-573

  Planté Bordeneuve, Violaine ^a   Said, G ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

AMYLOID NEUROPATHY; AMYLOIDOSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARDIOMYOPATHY; CLINICAL FEATURE; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENOTYPE; HEREDITY; HUMAN; LIVER TRANSPLANTATION; ONSET AGE; PHENOTYPE;

AMYLOID NEUROPATHIES; GENE FREQUENCY; HUMANS; MOLECULAR BIOLOGY; PREALBUMIN;

EID: 0033793972     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200010000-00011     Document Type: Article

References (57)

1. Inherited predisposition to generalized amyloidosis: Clinical and pathological study of a family with neuropathy, nephropathy and peptic ulcer
2. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms
3. A peculiar form of peripheral neuropathy
4. Structure of the chromosomal gene for human serum prealbumin
5. Transthyretin mutations in health and disease
6. Leptomeningeal amyloid and variant transthyretins
7. Screening and biochemical characterization of transthyretin variants in the Portuguese population
8. Haplotype analysis of common transthyretin mutations
9. New Transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy
10. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy
11. Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val → Met mutation most common to the disease
12. Compound heterozygotes of transthyretin Met30 and transthyretin Met119 are protected from the devastating effects of familial amyloid polyneuropathy
13. Comparative stability and clearance of [Met30] transthyretin and [Met119] transthyretin
14. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-Type I in Povoa do Varzim and Vila do Conde (North of Portugal)
15. Familial amyloidotic polyneuropathy in Sweden: Geographical distribution, age of onset, and prevalence
16. Genetic epidemiology of familial amyloid polyneuropathy in Majorca (Spain)
17. Genotypic and phenotypic spectrum of tranethyretin amyloidosis in the French population
18. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy
19. Anticipation in familial amyloid neuropathy type I (FAP-I): The possible role of a genetic modifier
20. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy
21. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions
22. Changes in the paradigm of Portuguese FAP patients: In the last 12 years, onset become later and new families come from distinct areas
23. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features
24. Influence of the transthyretin-Met119 variant on the Met30 familial amyloid polyneuropathy (FAP) in Portuguese and French cases
25. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: A clinicopathologic study
26. 55, a variant asociated with early onset aggressive, diffuse amyloidosis with cardiac and neurologic involvement
27. An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54
28. Late onset cardiac amyloidosis and transthyretin variants: Distinguishing between senile cardiac amyloidosis and familial amyloid cardiomyopathy
29. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly)
30. Transthyretin amyloidosis: A new mutation associated with dementia
31. Dementia in familial amyloidotic polyneuropathy (FAP) (ATTR Tyr114Cys)
32. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis
33. Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met) comparison of Swedish and Japanese patients
34. Two pairs of proven monozygotic twins discordant for familial amyloid neuropathy (FAP) TTR Met30
35. Sympathetic skin responses in hereditary sensory and autonomic neuropathy and familial amyloid polyneuropathy are different
36. Sensory nerves in skin. Answers about painful feet
37. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy
38. A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy
39. Single cell PCR for preimplantation diagnosis of V30 M familial amyloidotic polyneuropathy
40. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
41. Liver transplantation in familial amyloidotic polyneuropathy
42. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy
43. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
44. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation
45. The course and prognosis factors of familial amyloid polyneuropathy after liver transplantation
46. Liver transplantation for familial amyloid polyneuropathy - Report from the world register
47. Liver transplantation for familial amyloidotic polyneuropathy: The Coimbra university hospital experience
48. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis
49. Effect of orthotopic liver transplantation on the progression of familial amyloid polyneuropathy
50. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine 77 transthyretin variant
51. Cardiac morbidity and mortality in OLT for non-Met30 TTR associated FAP
52. Cardiac abnormalities in FAP patients: Results of a prospective study before liver transplantation
53. Long term results of liver transplantation in familial amyloid polyneuropathy type I
54. Partial-liver transplantation to treat familial amyloid polyneuropathy: Follow-up of 11 patients
55. Outcome of liver transplantation for transthyretin amyloidosis: Follow up of Japanese familial amyloidotic polyneuropathy patients
56. Domino liver transplants for metabolic disorders: Experience with familial amyloid polyneuropathy
57. Familial amyloidotic polyneuropathy: Domino liver transplantation